FDA Drug recall D-0850-2020
Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141
- FDA Drug
- Class II
- terminated
- Published 2020-02-26
On 2020-02-26 the FDA classified a Class II recall of Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141 by Ncs Healthcare, citing failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0850-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-01-28 |
| Published | 2020-02-26 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Ncs Healthcare |
| Distribution | US |
Product
Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.
Reason
Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
Identifiers
| code_info | Lot #: 8170-9004, Exp 01/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0850-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.